<DOC>
	<DOC>NCT02673606</DOC>
	<brief_summary>The goal of this project is to examine how estrogen may influence the resting-state connectivity and the extinction-induced activation of the fear extinction network.</brief_summary>
	<brief_title>Impact of Estrogen on Fear Extinction</brief_title>
	<detailed_description />
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>Righthanded Naturallycycling (regular cycle) No current or past history of Axis I psychiatric disorders Psychiatric, neurologic or medical condition that would interfere with study procedures or confound results, ascertained by history. History of seizure or significant head trauma (i.e., extended loss of consciousness, neurological sequelae, or known structural brain lesion). History of Axis I psychiatric diagnosis; e.g., history of substance use disorder, psychotic disorder, bipolar disorder, tic disorder, or eating disorder. Use of psychotropic medication within 4 weeks prior to study (within 6 weeks for fluoxetine, or other longlived compounds; within one year for neuroleptics). Pregnancy (to be ruled out by urine ÃŸHCG). Metallic implants or devices contraindicating magnetic resonance imaging. Use of oral contraceptives or nonoral contraceptives containing estrogen and progesterone within 3 months History of breast cancer. Allergy to peanut oil.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>